MARKET

PHBBF

PHBBF

PHARMARON BEIJIN
OTCMKTS

Real-time Quotes | Nasdaq Last Sale

--
0.00
0.00%
Closed 16:00 12/03 EST
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
BRIEF-Goldman Sachs' Long Position In Pharmaron Beijing Falls To 4.99% - HKEX Filing
reuters.com · 11/23 09:15
BRIEF-Goldman Sachs' Long Position In Pharmaron Beijing Falls To 4.95% - HKEX Filing
reuters.com · 11/02 09:12
BRIEF-Pharmaron Beijing Got Notice In Relation To Increase Of Size Of Legend Huikang Fund
reuters.com · 10/27 15:19
BRIEF-Pharmaron Beijing's Shareholders To Unload Up To A Combined 3% Stake In The Company
reuters.com · 09/24 08:55
BRIEF-BlackRock Inc's Long Position In Pharmaron Beijing Falls To 6.61% - HKEX Filing
reuters.com · 08/20 09:11
BRIEF-Capital Group Companies Inc's Long Position In Pharmaron Beijing Rises To 12.32% - HKEX Filing
reuters.com · 08/17 09:20
BRIEF-Pharmaron Beijing Says Kangjun Investment And 11 Limited Partners Including Co Entered Into Partnership Agreement
reuters.com · 08/12 12:34
BRIEF-Pharmaron Beijing Says Co, Lasa Junqi And 37 Other Partners Entered Into Limited Partnership Agreement
reuters.com · 07/27 14:46
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PHBBF. Analyze the recent business situations of PHARMARON BEIJIN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average PHBBF stock price target is 27.59 with a high estimate of 31.28 and a low estimate of 21.32.
High31.28
Average27.59
Low21.32
Current undefined
EPS
Actual
Estimate
0.020.040.070.09
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding:
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
Declaration Date
Dividend Per Share
Ex-Div Date
03/28/2021
Dividend HKD 0.362631544592801
06/02/2021
  • All
  • Financials
  • Insiders
No Data
About PHBBF
Pharmaron Beijing Co., Ltd. is a China-based company that provides research and manufacturing services throughout the discovery, development and manufacturing spectrum for small molecule drugs, cell therapies and gene therapies as well as providing testing services for medical devices and clinic research. The Company has four segments. The Laboratory Services segment includes laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, biology, safety assessment and discovery of biologics services. The Clinical Development Services segment includes clinical research, site management organization, regulatory bioanalysis and radiolabelled sciences service. The Chemistry, Manufactory and Control Services segment includes process development and manufacturing, material science/pre-formulation, formulation development and manufacturing and analytical development and commercial manufacturing services. The Company also operates Others segment.

Webull offers kinds of Pharmaron Beijing Co Ltd stock information, including OTCMKTS:PHBBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHBBF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PHBBF stock methods without spending real money on the virtual paper trading platform.